search
Back to results

Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest (SNOCAT)

Primary Purpose

Out-Of-Hospital Cardiac Arrest

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Placebo
sodium nitrite 45 mg
sodium nitrite 60 mg
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Out-Of-Hospital Cardiac Arrest

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Cardiac arrest, either VF or non-VF, patients receiving ACLS by paramedics
  • IV or IO access
  • Comatose

Exclusion Criteria:

  • traumatic cause of cardiac arrest
  • prisoner, pregnancy
  • known DNAR

Sites / Locations

  • Harborview Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Placebo

sodium nitrite

Arm Description

2 ml of normal saline (n=500)

45 mg IV of sodium nitrite (n=500) or 60 mg IV sodium nitrite (n=500) given during active resuscitation from out of hospital cardiac arrest.

Outcomes

Primary Outcome Measures

Number of Participants Who Survived to Hospital Admission
Patient has sustained pulse at arrival to the emergency department

Secondary Outcome Measures

Survival to Discharge
Patient alive at time of discharge from hospital
Number of Days in ICU
Number of days the patient is admitted to the Intensive Care Unit
Survival to 24 Hours
Patient is alive after the first 24 hours after admission to the hospital
Re-arrest
Patient loses pulses during transport to the hospital. Event occurs before admission to hospital.
Survival to 48 Hours After Admission to Hospital
Patient is alive after first 48 hours after admission to the hospital
Survival to 72 Hours After Admission to Hospital
Patient is alive after first 72 hours after admission to the hospital

Full Information

First Posted
February 12, 2018
Last Updated
April 27, 2023
Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
search

1. Study Identification

Unique Protocol Identification Number
NCT03452917
Brief Title
Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
Acronym
SNOCAT
Official Title
Randomized Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
February 8, 2018 (Actual)
Primary Completion Date
December 31, 2019 (Actual)
Study Completion Date
April 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
In this clinical study, a total of 1500 patients with out-of-hospital cardiac arrest in Seattle/King County will be enrolled. This will be a randomized clinical trial and patients will receive either two different doses of IV sodium nitrite (45 mg or 60 mg) or placebo during resuscitation in the field by paramedics. The primary outcome will be proportion of patients surviving to hospital admission.
Detailed Description
The hemodynamic effects of the optimal dose of IV nitrite administered in patients with cardiac arrest are unknown. A significant negative hemodynamic effect from nitrite would decrease the proportion of patients admitted to the hospital, increase rate of re-arrest, or increase the need for vasopressor support in the field. In Seattle/King County, typically 40% of out-of-hospital cardiac arrest patients attended to by paramedics have Return of spontaneous circulation (ROSC) and are admitted to the hospital. In this study, 1500 patients with out-of-hospital cardiac arrest who are undergoing resuscitation by paramedics will be randomized to receive placebo (n=500) or 45 mg IV (n=500) or 60 mg dose (n=500) of sodium nitrite. The study will have 80% power to detect an absolute increase in hospital admission rate of 8% (1-sided .05 level test for each of the two comparisons (45 mg vs placebo and 60 mg vs placebo, no adjustment for multiple comparisons), with a hospital admission rate of 40% in the placebo group and with one interim analysis and stopping only for potential futility and/or harm). The investigators will examine the proportion of patients who survive to discharge as a secondary measure of efficacy. Patients will be eligible for this study if: Intravenous access (IV)/intraosseous access(IO) Cardiac arrest, either Ventricular Fibrillation (VF) or non-VF patients receiving Advanced Cardiac Life Support (ACLS) by Seattle/King County paramedics. Age 18 years or older Comatose Exclusion Criteria Traumatic cause of cardiac arrest Prisoner, pregnancy, age less than 18 (special population/vulnerable population) Known DNAR Drowning as cause of arrest.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Out-Of-Hospital Cardiac Arrest

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1502 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
2 ml of normal saline (n=500)
Arm Title
sodium nitrite
Arm Type
Experimental
Arm Description
45 mg IV of sodium nitrite (n=500) or 60 mg IV sodium nitrite (n=500) given during active resuscitation from out of hospital cardiac arrest.
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
500 patients will 2 ml of normal saline
Intervention Type
Drug
Intervention Name(s)
sodium nitrite 45 mg
Intervention Description
500 patients will receive 45 mg IV sodium nitrite
Intervention Type
Drug
Intervention Name(s)
sodium nitrite 60 mg
Intervention Description
500 patients will receive a dose of 60 mg IV sodium nitrite
Primary Outcome Measure Information:
Title
Number of Participants Who Survived to Hospital Admission
Description
Patient has sustained pulse at arrival to the emergency department
Time Frame
within 24 hours after out of hospital cardiac arrest
Secondary Outcome Measure Information:
Title
Survival to Discharge
Description
Patient alive at time of discharge from hospital
Time Frame
within 3-6 months after cardiac arrest
Title
Number of Days in ICU
Description
Number of days the patient is admitted to the Intensive Care Unit
Time Frame
Within first 3 months of hospital admission
Title
Survival to 24 Hours
Description
Patient is alive after the first 24 hours after admission to the hospital
Time Frame
within first 24 h after hospital admission
Title
Re-arrest
Description
Patient loses pulses during transport to the hospital. Event occurs before admission to hospital.
Time Frame
before hospital arrival
Title
Survival to 48 Hours After Admission to Hospital
Description
Patient is alive after first 48 hours after admission to the hospital
Time Frame
within first 48 hours after admission to hospital
Title
Survival to 72 Hours After Admission to Hospital
Description
Patient is alive after first 72 hours after admission to the hospital
Time Frame
within first 72 hours after admission to hospital

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Cardiac arrest, either VF or non-VF, patients receiving ACLS by paramedics IV or IO access Comatose Exclusion Criteria: traumatic cause of cardiac arrest prisoner, pregnancy known DNAR
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Francis Kim, MD
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
Harborview Medical Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98104
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
Citations:
PubMed Identifier
33433575
Citation
Kim F, Maynard C, Dezfulian C, Sayre M, Kudenchuk P, Rea T, Sampson D, Olsufka M, May S, Nichol G. Effect of Out-of-Hospital Sodium Nitrite on Survival to Hospital Admission After Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2021 Jan 12;325(2):138-145. doi: 10.1001/jama.2020.24326.
Results Reference
derived

Learn more about this trial

Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest

We'll reach out to this number within 24 hrs